Newron Overcomes 2011 Disappointments, Moves To Boost CNS Pipeline With NeuroNova Acquisition
This article was originally published in The Pink Sheet Daily
Executive Summary
Italy's Newron aims to become a leading European CNS-focused biotech company with the proposed acquisition of Sweden's NeuroNova adding product candidates in ALS and Parkinson's disease to its portfolio.